Enhanced activation of human t cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3725-3734

  Zhu, MingZhu ^a   Terasawa, Hiroshi ^a   Gulley, James ^a   Panicali, Dennis ^b   Arlen, Philip ^a   Schlom, Jeffrey ^a   Tsang, Kwong Y ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Therion Biologics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT CYTOKINE; RECOMBINANT TRICOM; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FOWLPOX VIRUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD58; ANTIGENS, CD80; DENDRITIC CELLS; FOWLPOX VIRUS; GENETIC VECTORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0035328585     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Clonal expansion versus functional clonal inactivation: A costimulatory signaling pathway determines the outcome of T-cell antigen receptor occupancy
2. Costimulation of T-cell growth
3. Immunosuppression through blockade of CD28: B7-mediated costimulatory signals
4. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells
5. The diversity of T-cell costimulation in induction of antitumor immunity
6. Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules
7. Bone marrow-generated dendritic cells pulsed with a class I restricted peptide are potent inducers of cytotoxic T lymphocytes
8. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
9. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-α for use in cancer immunotherapy
10. The role of IL-13 in the generation of dendritic cells in vitro
11. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
12. Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire
13. Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors
14. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells
15. Dendritic cells: A link between innate and adaptive immunity
16. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
17. Selective in vivo mobilization with granulocyte-macrophage colony-stimulating factor (GM-CSF): Granulocyte-macrophage CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitors in patients with advanced breast cancer undergoing autologous transplantation
18. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T-cell stimulatory capacity: T-T help via APC activation
19. Dendritic cells and the control of immunity
20. Human dendritic cells activate T lymphocytes in a CD40:CD40 ligand-dependent pathway
21. Optimization of the sequence of antigen loading and CD40 ligand-induced maturation of dendritic cells
22. A triad of costimulatory molecules synergize to amplify T-cell activation
23. Poxvirus-based vectors as vaccine candidates
24. Preclinical evaluation of an ALVAC (canarypox) human cytomegalovirus glycoprotein B vaccine candidate
25. Phase I study in cancer patients of a diversified prime and boost immunization protocol using recombinant vaccinia virus and recombinant non-replicating avianpox virus to elicit an anticarcinoembryonic antigen immune response
26. Human dendritic cells (DC) infected with Avipox (ALVAC) encoding human carcinoembryonic antigen (CEA) and costimulatory molecule B7.1 enhanced induction of specific T-cell responses in vitro
27. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine
28. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
29. Induction of primary human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides
30. Structure, expression, and T-cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
31. Isolation of the murine intercellular adhesion molecules 1 (ICAM-1) gene, ICAM-1 enhances antigen-specific T-cell activation
32. Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein
33. NK susceptibility varies inversely with target cell class I HLA antigen expression
34. Mutations in the α 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide
35. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
36. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen
37. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood: General sedimentation properties of white blood cells in a 1 g gravity field
38. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte-macrophage colony-stimulating factor plus interleukin-4, and downregulated by tumor necrosis factor-α
39. Recombinant vaccinia virus: Immunization against multiple pathogens
40. Sequence and transcriptional analysis of the vaccinia virus Hind III fragment
41. Compact, synthetic vaccinia virus early/late promoter for protein expression
42. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen
43. Agonist peptide from a cytotoxic T-lymphocyte epitope of human carcinoembryonic antigen stimulates production of Tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide
44. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
45. HLA-A2-restricted peripheral blood cytolytic T lymphocytes respond to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions
46. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen
47. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-γ
48. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
49. Enhanced generation of cytotoxic T lymphocytes using recombinant vaccinia virus expressing human tumor-associated antigens and B7 costimulatory molecules
50. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T-cell proliferation
51. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes
52. Expression and functional significance of an additional ligand for CTLA-4
53. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation
54. CD28-mediated signaling costimulates murine T cells and prevents induction of anergy in T-cell clones
55. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
56. Fas ligand is expressed on human squamous cell carcinomas of the head and neck and it promotes apoptosis of T lymphocytes
57. Bc12 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
58. The roles of costimulation on Fas in T-cell apoptosis and peripheral tolerance
59. CD28 costimulation can promote T-cell survival by enhancing the expression of Bcl-Xl
60. Interleukin-2: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
61. Soluble CD14 participates in the response of cells to lipopolysaccharide
62. Monocyte-regulated IFN-γ production in human T cells involves CD2 signaling